Drug Shortage Report for MARCAINE
Report ID | 189856 |
Drug Identification Number | 02241917 |
Brand name | MARCAINE |
Common or Proper name | MARCAINE |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | BUPIVACAINE HYDROCHLORIDE |
Strength(s) | 150MG |
Dosage form(s) | SOLUTION SOLUTION |
Route of administration | EPIDURAL RETROBULBAR EPIDURAL RETROBULBAR |
Packaging size | 10 x 20mL vial |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-04-18 |
Estimated end date | |
Actual end date | 2023-04-27 |
Shortage status | Resolved |
Updated date | 2023-04-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-04-28 | French | Compare |
v3 | 2023-04-28 | English | Compare |
v2 | 2023-04-19 | French | Compare |
v1 | 2023-04-19 | English | Compare |
Showing 1 to 4 of 4